Clinical Trials Logo

Anxiety Disorders clinical trials

View clinical trials related to Anxiety Disorders.

Filter by:

NCT ID: NCT05951257 Recruiting - Anxiety Clinical Trials

Medical Hypnosis and Music for Palliative Care

MuzhypforPC
Start date: April 13, 2022
Phase: N/A
Study type: Interventional

The goal of this randomized controlled trial is to evaluate the efficacy of a personalized multimodal intervention program (MuzHyp) including hypnosis, music or their combination to improve palliative care at home. The main objective is to evaluate if the intervention program will significantly reduce participants' composite score of pain, anxiety, and unwellness as evaluated by the Edmonton symptom assessment scale (ESAS) immediately after the intervention, and whether this improvement will be significantly greater than that of control sessions.

NCT ID: NCT05950698 Recruiting - Obesity Clinical Trials

Obesity and Bariatric Surgery According to a Biopsychosocial Perspective.

Start date: October 20, 2022
Phase:
Study type: Observational

- The main goal of this prospective longitudinal observational study is to investigate the psychophysiological indicators by analyzing HRV, blood pressure, symptoms of anxiety and depression, eating behavior and quality of life during the follow-up of the general health status of patients with obesity undergoing the bariatric surgery by Roux-en-Y reconstruction reduction gastroplasty (GRYR) technique. - The main question it aims to answer is: Does bariatric surgery changes the variables studied (HRV, anxiety, depression, eating behavior, quality of life)? - Type of study: prospective longitudinal observational study - Participant population: 50 patients, both females and males, aged between 18 and 60 years, will be submitted to bariatric surgery with Roux-en-Y reconstruction reduction gastroplasty technique. Patients will be evaluated for five times: before the bariatric surgery and 3-6-12-24 months after the bariatric surgery.

NCT ID: NCT05948748 Recruiting - Surgery Clinical Trials

Level of Anxiety in Patients Undergoing Invasive Foot Surgery

Start date: July 10, 2023
Phase:
Study type: Observational [Patient Registry]

Preoperative anxiety has been studied in different medical disciplines, but it is unknown in minor surgical procedures such as foot nail surgery. This study aimed to determine the prevalence of preoperative anxiety and postoperative pain in foot nail surgery. The validated Amsterdam preoperative anxiety and information scale (APAIS) was used to evaluate preoperative anxiety and the need for information in 155 patients undergoing foot nail surgery. In addition, a questionnaire was used to collect other variables such as age, sex and educational level. The verbal numeric scale was employed to value the postoperative pain after 24 h.

NCT ID: NCT05946382 Recruiting - Anxiety Clinical Trials

A Comparison of Two Ultra-brief Interventions in Primary Care for Patients With Anxiety, Depression, and Stress.

RNTACTSweden
Start date: February 7, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare the effect and time consumption of the Swedish translation of the protocol for RNT-ACT with the internet administrated self-help treatment with therapist support (iCBT) for patients seeking medical care for depression, anxiety or stress at their primary care unit. The trial consists of a feasibility study and a randomized controlled trial with 3- and 12-month follow ups.

NCT ID: NCT05943418 Not yet recruiting - Anxiety Clinical Trials

Examining the Effectiveness of Wysa for Worry Program

Start date: August 2023
Phase: N/A
Study type: Interventional

The goal of this randomized controlled trial is to test for the effectiveness of Wysa's Worry computerized cognitive behaviour therapy (cCBT) program (a digital mental health intervention) in comparison to a digital app that offers psychoeducation to patients who have mild to moderate symptoms of anxiety.

NCT ID: NCT05942560 Not yet recruiting - Depression Clinical Trials

Effects of CBT-Based Intervention Among Patients With Liver Cancer

Start date: December 30, 2023
Phase: N/A
Study type: Interventional

This study investigates the effects of a CBT- based intervention on depression, anxiety, immune function, quality of life, and overall survival. It also explores if the effects of the intervention on immune function and quality of life are mediated through the improvements in depression and anxiety among patients with liver cancer.

NCT ID: NCT05942495 Recruiting - Anxiety Disorders Clinical Trials

SFGT for Persistent Anxiety and Depression

Start date: July 18, 2023
Phase: N/A
Study type: Interventional

Rationale: Although there are effective treatments available for anxiety and depression, there is a large group of clients that does not benefit sufficiently from first-choice treatment. For this group of clients, no suitable alternative exists yet. One of the main hypothesis about maintaining factors is that there are underlying personality features that impede recovery. Schema focused therapy (SFT) is a transdiagnostic therapy focusing on underlying personality features. It has been proven to be an effective therapy for people with personality disorders and there are initial indications that SFT is also an effective treatment for anxiety and depressive symptoms. A short-term schema focused group therapy (SFGT) has been developed within GGZ-NHN, which is expected to benefit clients with persistent anxiety and depressive symptoms, but has not yet been studied. Objective of the study: In the present study the effectiveness of short-term SFGT (protocol of De Jager, Burger & Groot) on (1) persistent anxiety and depressive symptoms, and (2) early maladaptive schemas (EMS), experiential avoidance and the mode of the healthy adult will be investigated.

NCT ID: NCT05942391 Not yet recruiting - Anxiety Disorders Clinical Trials

Brief-intensive CBT Versus Once-weekly CBT in Anxiety-related Disorders

KOMMA
Start date: December 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare brief-intensive cognitive-behaviour therapy (CBT) with regular weekly CBT in people with anxiety-related disorders. The main question to answer is: will brief-intensive CBT improve functioning (work, family, social) more and faster than does regular weekly CBT? Participants will be asked to follow CBT treatment (20 sessions of 45 minutes in both conditions), and participate in 7 measurements with a total duration of 5 hours over 1 year. Researchers will compare: - Brief-intensive CBT: 16 sessions in 2 weeks + 4 follow-up sessions within 3 months - Regular CBT with 20 weekly sessions in 6 months

NCT ID: NCT05936905 Enrolling by invitation - HIV/AIDS Clinical Trials

Acupuncture Therapy VS Chiropractor Group Therapy to Reduce Anxiety and Depression.

Start date: July 6, 2023
Phase: N/A
Study type: Interventional

This study aims to determine and compare acupuncture therapy and chiropractor group therapy to reduce anxiety and depression among HIV/AIDS patients at Being Alive, Los Angeles. In this controlled clinical trial, a total of 30 patients will be divided into two groups, 15 in the acupuncture therapy group, 15 in the chiropractor group therapy. The Hospital Anxiety and Depression Scale (HADS), The Patient Health Questionnaire 9-item (PHQ-9) and Generalized Anxiety Disorder 7- item scales (GAD-7) will be used as screening tools for depressive and anxiety symptoms respectively.

NCT ID: NCT05932095 Recruiting - Anxiety State Clinical Trials

TCM Daoyin in the Treatment of Patients With Anxiety State

Start date: June 13, 2023
Phase: N/A
Study type: Interventional

In recent years, the number of people with symptoms of anxiety are on the rise. TCM Daoyin is a promising intervention for anxiety. This study is designed to allow researchers to better understand the changes in anxiety symptom, brain activity, and immune function during patients with anxiety states receiving TCM Daoyin intervention. Thus, the aims of the prospective randomized study are: (1) to examine the effects of TCM Daoyin training on reducing symptoms of anxiety, (2) to measure brain activity by using functional magnetic resonance imaging (fMRI), and (3) to assess Immune function.